Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Vascular tone refers to the degree of constriction or dilation in blood vessels, determined primarily by the contractile state of vascular smooth muscle cells within the vessel wall[1][7][9]. It is a physiological property rather than a discrete molecular entity. Vascular tone plays an essential role in regulating systemic and local blood pressure, ensuring adequate tissue perfusion under varying physiological conditions such as exercise or stress[1]. Its regulation involves complex interactions between neural inputs (sympathetic/parasympathetic nervous systems), hormonal signals (adrenaline, angiotensin II), local metabolic factors, and endothelial-derived mediators like nitric oxide[1][4][8]. Abnormalities in vascular tone contribute to diseases such as hypertension when excessive vasoconstriction occurs or shock when there is excessive vasodilation[5]. Many drugs—including alpha agonists/antagonists, calcium channel blockers, ACE inhibitors, nitrates—modulate vascular tone indirectly by acting on receptors or enzymes involved in these regulatory pathways. However, "vascular tone" itself is not a single therapeutic target but rather an emergent property resulting from multiple underlying molecular targets. Because "vascular tone" does not refer to any specific molecule/receptor/enzyme/transporter, it should not be considered a canonical drug target. Instead, it describes the net effect produced by various cellular mechanisms within the vasculature. “Vascular tone refers to the degree of constriction experienced by a blood vessel relative to its maximally dilated state… primarily influenced by smooth muscle cells in the vessel walls.”[9][1] “The regulation of vascular smooth muscle contraction… alters blood vessel volume and local blood pressure… Excessive vasoconstriction causes hypertension while excessive vasodilation leads to hypotension.”[5] In summary: "Vascular tone" is not itself a valid molecular drug target but rather describes an important physiological parameter controlled by numerous underlying targets.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vascular tone.